Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2Breast 1

Conditions

Breast Neoplasms 12Neoplasms 4Recurrence 3Squamous Cell Carcinoma of Head and Neck 2Neoplasms by Site 2Neoplasm Metastasis 2Head and Neck Neoplasms 2Endometrial Neoplasms 2Breast Diseases 2Brain Neoplasms 2Uterine Cervical Neoplasms 1Unilateral Breast Neoplasms 1Triple Negative Breast Neoplasms 1Spinal Cord Neoplasms 1Recurrent Ovarian High Grade Serous Adenocarcinoma 1Ovarian Neoplasms 1Neurofibromatosis 1 1Neoplasms, Squamous Cell 1Multiple Myeloma 1Meningioma 1Lymphoma, Non-Hodgkin 1Locally Advanced (Inoperable) or Metastatic Breast Cancer 1Liposarcoma 1Hereditary Sensory and Autonomic Neuropathies 1HR+/HER2- Breast Cancer 1Glioma 1Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer 1Central Nervous System Neoplasms 1Central Nervous System Diseases 1Brain Diseases 1

Interventions

Radiosurgery 7Temozolomide 6pembrolizumab 4Magnetic Resonance Spectroscopy 4Bevacizumab 4Specimen Handling 3Nivolumab 3abemaciclib 2Watchful Waiting 2Surveys and Questionnaires 2Receptors, Interleukin-8B 2Radiation 2Mental Status and Dementia Tests 2Memantine 2Ipilimumab 2Biopsy 2vorasidenib 1sotorasib 1sapanisertib 1ribociclib 1pertuzumab 1osimertinib 1lenvatinib 1fluciclovine F-18 1entrectinib 1encorafenib 1elacestrant 1dexamethasone acetate 1dexamethasone 21-phosphate 1brivaracetam 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Brain Neoplasms × abemaciclib × 30 days × Clear all
NCT05386108 2026-06-04

ELECTRA

Stemline Therapeutics, Inc.

Phase 1/2 Recruiting
73 enrolled
BreastCNS

Brain Diseases, Brain Neoplasms, Breast Diseases, Breast Neoplasms, Central Nervous System Diseases, Neoplasms, Neoplasms by Site, Central Nervous System Neoplasms

NCT06413706 2026-05-22

A Study Comparing Abemaciclib Plus Temozolomide to Temozolomide Monotherapy in Children and Young Adults With High-grade Glioma Following Radiotherapy

Eli Lilly and Company

Phase 2 Active not recruiting
45 enrolled
CNS

Brain Neoplasms, Glioma, Neoplasms, Spinal Cord Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡